Metro Boston Clinical Partners ( Site 0110) — Brighton, Massachusetts

Metro Boston Clinical Partners ( Site 0110) is a clinical research site located in Brighton, Massachusetts, United States 02135.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Metro Boston Clinical Partners ( Site 0110) has participated in 1 clinical trials.

Therapeutic areas: Non-segmental Vitiligo.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro Boston Clinical Partners ( Site 0110)?

Metro Boston Clinical Partners ( Site 0110) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro Boston Clinical Partners ( Site 0110) conducted?

Metro Boston Clinical Partners ( Site 0110) has 1 clinical trials on record. Their work covers Non-segmental Vitiligo.

Is Metro Boston Clinical Partners ( Site 0110) accredited by Crixeo Health?

Metro Boston Clinical Partners ( Site 0110) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro Boston Clinical Partners ( Site 0110)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.